Modulation of the pharmacokinetics of macromolecular contrast material by avidin chase: MRI, optical, and inductively coupled plasma mass spectrometry tracking of triply labeled albumin

被引:50
作者
Dafni, H
Gilead, A
Nevo, N
Eilam, R
Harmelin, A
Neeman, M [1 ]
机构
[1] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel
[2] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel
关键词
albumin; vascular permeability; arterial input function; avidin chase; MAGNETIC-RESONANCE; BIOTIN TECHNOLOGY; BLOOD CLEARANCE; GROWTH-FACTOR; STREPTAVIDIN; ANTIBODIES; TUMOR; IGG; RADIOIMMUNOTHERAPY; BIODISTRIBUTION;
D O I
10.1002/mrm.10638
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The goal of this work was to develop an MRI method for mapping the clearance of interstitial macromolecular plasma proteins after their extravasation from permeable blood vessels. To that end, a well-defined window of exposure to elevated blood levels was generated by inducing rapid clearance of macromolecular contrast material from the blood. Experimental removal of the intravascular component allowed subsequent tracking of clearance from the interstitial compartment in the absence of further contrast extravasation. The contrast material was based on albumin triply labeled with biotin, fluorescent tag, and Gd-DTPA, allowing optical, inductively coupled plasma mass spectrometry (ICP-MS) and MRI detection. The biotin tag was used here for in vivo chasing of the contrast material from the blood by intravenous administration of avidin. Upon administration of avidin the contrast material disappeared from the blood vessels and was cleared by the liver and spleen as detected by MRI, fluorescence of blood samples and histological sections, and by ICP-MS. Nonbiotinylated fluorescent albumin was not affected by administration of avidin. Contrast material that extravasated from leaky blood vessels in a VEGF overexpressing tumor, prior to administration of avidin, was not cleared by the addition of avidin and showed continued interstitial convection. Thus, avidin-chase provides an effective tool for in vivo manipulation of the arterial input function by providing experimental control over the rate of clearance of the contrast material from the circulation. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:904 / 914
页数:11
相关论文
共 24 条
  • [1] BAYER EA, 1990, METHOD ENZYMOL, V184, P49
  • [2] Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
    Benjamin, LE
    Golijanin, D
    Itin, A
    Pode, D
    Keshet, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) : 159 - 165
  • [3] Bhujwalla Z M, 1999, Top Magn Reson Imaging, V10, P92, DOI 10.1097/00002142-199904000-00002
  • [4] Assessing tumor angiogenesis using macromolecular MR imaging contrast media
    Brasch, R
    Pham, C
    Shames, D
    Roberts, T
    vanDijke, K
    vanBruggen, N
    Mann, J
    Ostrowitzki, S
    Melnyk, O
    [J]. JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1997, 7 (01): : 68 - 74
  • [5] Brunskill NJ, 1998, EXP NEPHROL, V6, P491
  • [6] MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor
    Dafni, H
    Landsman, L
    Schechter, B
    Kohen, F
    Neeman, M
    [J]. NMR IN BIOMEDICINE, 2002, 15 (02) : 120 - 131
  • [7] Dafni H, 2002, CANCER RES, V62, P6731
  • [8] Preparation, biodistribution, and dosimetry of 188Re-labeled MoAb ior ceal and its F(ab′)2 fragments by avidin-biotin strategy
    Ferro-Flores, G
    Pimentel-González, G
    González-Zavala, MA
    de Murphy, CA
    Meléndez-Alafort, L
    Tendilla, JI
    Croft, BY
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (01) : 57 - 62
  • [9] Applications of magnetic resonance in model systems: Tumor biology and physiology
    Gillies, RJ
    Bhujwalla, ZM
    Evelhoch, S
    Garwood, M
    Neeman, M
    Robinson, SP
    Sotak, CH
    Van der Sanden, B
    [J]. NEOPLASIA, 2000, 2 (1-2): : 139 - 151
  • [10] KLIBANOV AL, 1988, J NUCL MED, V29, P1951